Uterine Corpus Leiomyosarcoma
📧 Sign up to get email alerts when something new happens for Uterine Corpus Leiomyosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working [Phase 2, Phase 3]
A Phase 2/Phase 3 trial comparing olaparib plus temozolomide to the usual treatment for locally advanced or metastatic uterine corpus leiomy…
-
CLINICAL_TRIALS trial_result · 2023-08-16Clinical Trial Update: Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery [NA]
A terminated clinical trial evaluating gemcitabine hydrochloride, docetaxel, and radiation therapy for uterine sarcoma that was surgically r…
-
CLINICAL_TRIALS research · 2019-07-23Clinical Trial Update: Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus [Phase 2]
Phase 2 trial evaluating thalidomide for recurrent or persistent cancer of the uterus has been completed.
-
CLINICAL_TRIALS trial_result · 2017-07-14Clinical Trial Update: Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma [Phase 3]
Phase 3 trial evaluating gemcitabine hydrochloride and docetaxel with or without bevacizumab in advanced or recurrent uterine leiomyosarcoma…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus [Phase 2]
A Phase 2 trial evaluating combination chemotherapy with filgrastim or pegfilgrastim in patients with recurrent or persistent cancer of the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy [Phase 2]
A phase 2 clinical trial evaluating ixabepilone for recurrent or persistent uterine leiomyosarcoma after prior chemotherapy has completed wi…
-
CLINICAL_TRIALS trial_result · 2015-07-17Clinical Trial Update: Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus [Phase 2]
Phase 2 trial of alisertib for recurrent or persistent uterine leiomyosarcoma completed; results posted in 2015.